Blue Bird's stock soared 8.09% during intraday trading on Thursday, reflecting strong positive momentum.

The surge appears driven by a series of positive analyst actions, with multiple firms raising or maintaining optimistic price targets. Barclays increased its target to $55 from $50, Needham raised its target to $78 from $70 while reiterating its Buy rating, and BofA lifted its target to $65 from $62 while maintaining a Buy rating. Additionally, BTIG maintained its $65 price target.

These upward revisions and maintained positive ratings indicate growing analyst optimism about Blue Bird's future performance, which has bolstered investor confidence and contributed to the stock's significant gain during the trading session.